Management of Double-Seropositive Anti-Glomerular Basement Membrane and Anti-Neutrophil Cytoplasmic Antibodies with 100% Crescentic Glomerulonephritis and Nephrotic Range Proteinuria in a Young Female

Biomedicines. 2024 Apr 19;12(4):906. doi: 10.3390/biomedicines12040906.

Abstract

Nephrotic range proteinuria in the setting of dual-positive anti-glomerular basement membrane (AGBM) and anti-neutrophil cytoplasmic antibodies (ANCAs) is rare. Furthermore, using rituximab as a primary immunosuppressant along with steroids and plasmapheresis has not been widely studied. We present a case of dual AGBM and ANCA with nephrotic range proteinuria in a young female, where rituximab was used as a primary immunosuppressant with partial recovery.

Keywords: anti-glomerular basement membrane; anti-neutrophil cytoplasmic antibodies; crescentic glomerulonephritis; nephrotic range proteinuria; rituximab.

Publication types

  • Case Reports

Grants and funding

The research received no external funding.